Related Experiment Videos
Amphetamines to counteract opioid-induced sedation
P J Corey1, A M Heck, R A Weathermon
1Milwaukee Heart Institute, WI, USA.
The Annals of Pharmacotherapy
|January 12, 2000
Summary
Amphetamines may help some patients with opioid-induced sedation when other options fail. However, general use is not recommended, and more research is needed to determine optimal use for this side effect.
Area of Science:
- Pharmacology
- Pain Management
- Adverse Effect Management
Background:
- Opioid therapy is crucial for pain management but often causes dose-limiting sedation.
- Amphetamines and their derivatives have been explored as potential counteragents for opioid-induced sedation.
Purpose of the Study:
- To review existing data on the efficacy of amphetamines and amphetamine derivatives in mitigating opioid-induced sedation.
- To assess the potential role of these agents in managing a significant adverse effect of opioid therapy.
Main Methods:
- Literature review of studies evaluating amphetamines (e.g., mazindol, dextroamphetamine, methylphenidate) for opioid-induced sedation.
- Analysis of reported outcomes and limitations of using these stimulants.
Main Results:
- Existing reports show limited success with amphetamines and their derivatives in counteracting opioid-induced sedation.
- These agents may offer benefits for a subset of patients experiencing severe, dose-limiting sedation.
Conclusions:
- Widespread use of amphetamines for opioid-induced sedation is not advised.
- Further research is necessary to identify suitable patient candidates, optimal stimulant choices, and precise dosages for this indication.